Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

monafram

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Factor XIIIa (fXIIIa) is a transglutaminase that plays a crucial role in fibrin clot stabilization and regulation of fibrinolysis… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
It is commonly known that red blood cell (RBC) tendency to reversibly aggregate contribute to the unique flow properties of blood… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2012
2012
There are complex interactions between blood cells, and erythrocytes may enhance platelet aggregation. However, there is a lack… Expand
  • table 1
  • table 2
Is this relevant?
2012
2012
Platelets are formed elements of blood. Upon activation, they externalize phosphatidylserine, thus accelerating membrane… Expand
Is this relevant?
2011
2011
Aim. To study of efficacy and safety of glycoprotein IIb/IIIa blocker monafram in acute ST-segment elevation myocardial… Expand
Is this relevant?
2010
2010
Glycoprotein (GP) llb-llla anagonist monafram is the F(ab)2 fragments of anti GP llb llla monoclonal antibody FraMon (CRC64… Expand
Is this relevant?
2007
2007
We investigated the influence of glycoprotein (GP) IIIa Leu33Pro polymorphism, platelet GP IIb-IIIa number, and plasma fibrinogen… Expand
Is this relevant?
2005
2005
The ability of different ligands of glycoprotein (GP) IIb-IIIa (αIIb/β3-integrin) to support platelet aggregation stimulated by… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
New glycoprotein (GP) IIb-IIIa antagonist preparation framon (Monafram), is the F(ab')(2) fragment of a monoclonal antibody… Expand
Is this relevant?
2004
2004
First Russian glycoprotein (GP) IIb-IIIa antagonist, preparation Monafram, is the F(ab')2 fragment of anti-GP IIb-IIIa monoclonal… Expand
Is this relevant?